Cyclerion Therapeutics Inc
CYCN1.100USD
+0.020+1.85%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
4.06M시가총액
손실P/E TTM
자세한 내용은 Cyclerion Therapeutics Inc 회사
Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering therapies for central nervous system (CNS) diseases. The Company is focused on building a pipeline with therapeutics to treat certain neuropsychiatric diseases. It is focused on an individualized therapy for treatment-resistant depression (TRD) - a condition with significant unmet medical need. Its assets include Olinciguat and Praliciguat. The Company has entered into an exclusive license option agreement for its vascular soluble guanylate cyclase (sGC) stimulator, olinciguat. Praliciguat is an oral, once-daily, systemic sGC stimulator that is licensed to Akeibia Therapeutics, Inc and is being advanced in rare kidney disease.
Cyclerion Therapeutics Inc 정보
종목 코드 CYCN
회사 이름Cyclerion Therapeutics Inc
상장일Mar 18, 2019
CEOGraul (Regina M)
직원 수1
유형Ordinary Share
회계 연도 종료Mar 18
주소301 Binney Street
도시CAMBRIDGE
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02142
전화16176217722
웹사이트https://www.cyclerion.com/
종목 코드 CYCN
상장일Mar 18, 2019
CEOGraul (Regina M)
Cyclerion Therapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
+1650.00%
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Rhonda M. Chicko
Ms. Rhonda M. Chicko
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Peter M. Hecht, Ph.D.
Dr. Peter M. Hecht, Ph.D.
Director
Director
559.20K
--
Dr. Errol B. De Souza, Ph.D.
Dr. Errol B. De Souza, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
50.00K
--
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Director
Independent Director
30.74K
+1650.00%
Dr. Dina Katabi, Ph.D.
Dr. Dina Katabi, Ph.D.
Independent Director
Independent Director
20.00K
--
Dr. Steven E. Hyman, M.D.
Dr. Steven E. Hyman, M.D.
Independent Director
Independent Director
--
--
Dr. Regina M. Graul, Ph.D.
Dr. Regina M. Graul, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 31
마지막 업데이트: Sat, Jan 31
주주
주주 유형
주주
주주
비율
Hecht (Peter M)
14.25%
J. Wood Capital Advisors LLC
4.63%
American Endowment Foundation
3.39%
Invus Public Equities Advisors, LLC
2.96%
Graul (Regina Margaret)
1.42%
기타
73.35%
주주
주주
비율
Hecht (Peter M)
14.25%
J. Wood Capital Advisors LLC
4.63%
American Endowment Foundation
3.39%
Invus Public Equities Advisors, LLC
2.96%
Graul (Regina Margaret)
1.42%
기타
73.35%
주주 유형
주주
비율
Individual Investor
18.74%
Corporation
8.02%
Investment Advisor
5.71%
Investment Advisor/Hedge Fund
0.95%
Hedge Fund
0.40%
Research Firm
0.02%
기타
66.15%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
33
277.64K
23.79%
--
2025Q3
36
277.64K
28.05%
-103.98K
2025Q2
36
381.62K
29.96%
-10.58K
2025Q1
53
392.20K
30.91%
-599.93K
2024Q4
57
398.50K
41.58%
-660.57K
2024Q3
62
1.11M
44.54%
-7.58K
2024Q2
66
1.10M
44.98%
-18.58K
2024Q1
76
1.12M
48.61%
-196.27K
2023Q4
83
1.12M
54.12%
-3.34K
2023Q3
98
1.12M
59.61%
-44.82K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Hecht (Peter M)
559.20K
14.25%
--
--
Apr 21, 2025
J. Wood Capital Advisors LLC
181.82K
4.63%
--
--
Aug 01, 2025
American Endowment Foundation
133.03K
3.39%
+133.03K
--
Dec 31, 2024
Invus Public Equities Advisors, LLC
116.16K
2.96%
--
--
Sep 30, 2025
Graul (Regina Margaret)
55.78K
1.42%
-44.52K
-44.39%
Apr 21, 2025
De Souza (Errol B)
50.00K
1.27%
--
--
Apr 21, 2025
DRW Securities, LLC
43.62K
1.11%
+43.62K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
37.16K
0.95%
+4.42K
+13.51%
Sep 30, 2025
Higgins (Michael J)
30.74K
0.78%
+1.65K
+5.67%
Apr 21, 2025
The Vanguard Group, Inc.
23.49K
0.6%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Fidelity Nasdaq Composite Index ETF
0%
Fidelity Nasdaq Composite Index ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
날짜
배당락일
유형
비율
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
May 15, 2023
Merger
20→1
